Skip to content
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
Search
Search
Close
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
×
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
0
0
Sub-Total:
$
0.00
No products in the cart.
100% Secure Checkout!
Home
/
Specialty
/
Dermatology
/ Emerging Biological Therapies for Psoriasis: Promising Efficacy of Interleukin‐17 (IL‐17) and IL‐23 Pathway Inhibitors
Emerging Biological Therapies for Psoriasis: Promising Efficacy of Interleukin‐17 (IL‐17) and IL‐23 Pathway Inhibitors
Complimentary
Categories:
Activity Type
,
Online Activity
,
Credit Type
,
ANCC
,
CME
,
Dermatology
,
Pediatrics
,
Profession
,
Nurse
,
Nurse Practitioner
,
Physician
,
Physician Assistant
,
Rheumatology
Related products
Novel Treatment and Management Options for Chronic Idiopathic Constipation
Read more
New Paradigms in the Biological Therapies for Atopic Dermatitis
Read more
New Paradigms in the Clinical Practice of Inflammatory Bowel Diseases
Read more
New Paradigms in the Treatment and Management of Age-related Macular Degeneration (AMD)
Read more
Scroll To Top